Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Apyx Medical Corporation (APYX)
USD4.33
+0.11 (+2.61%)
US NASDAQ Healthcare Medical - Specialties
Address
5115 Ulmerton Road 33760-4004
Clearwater, FL, US
Clearwater, FL, US
CEO
Charles D. Goodwin
Website
apyxmedical.com
IPO
2019-01-02
CIK 719135 ISIN US03837C1062
Also trades on
NASDAQ Global Select · APYX (USD)
NASDAQ Global Select · BVX (USD)
Description
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.33
+0.11 (+2.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
179.9K
Beta
1.37
Float Shares
36.28M
Free Float %
86.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.34% | +20.29% | +5.41% | +9.95% | +0.49% | +16.86% | +158.86% | -26.96% | -57.84% | -36.79% | -36.79% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
4.33
Low
6.00
+38.6%
Consensus
6.00
+38.6%
Median
6.00
+38.6%
High
6.00
+38.6%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
6.00
+38.6%
|
| Last Year | 2 |
6.00
+38.6%
|
| All Time | 5 |
9.20
+112.5%
|
Quality scores
Altman Z-Score
1.50
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+9.9% ★ Q1'26: +32.4% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%+59.1% ★ Q1'26: +58.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-26.3% Q1'26: -5.1% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%-12.2% Q1'26: -7.3% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%-28.7% Q1'26: -17.0% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%+18.6% Q1'26: +18.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-6.79× Q1'26: -13.91× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
29.52M
est: 29.90M (-1.3%)
|
36.63M
est: 36.93M (-0.8%)
|
38.88M
est: 37.35M (+4.1%)
|
16.69M
est: 16.72M (-0.2%)
|
28.24M
est: 27.71M (+1.9%)
|
27.71M
est: 26.50M (+4.6%)
|
48.52M
est: 46.32M (+4.7%)
|
44.51M
est: 44.84M (-0.7%)
|
52.35M
est: 49.03M (+6.8%)
|
48.10M
est: 47.28M (+1.7%)
|
52.84M
est: 52.22M (+1.2%)
|
59.56M
58.67M – 60.20M
+14.1% YoY
|
65.76M
64.77M – 66.46M
+10.4% YoY
|
76.40M
75.25M – 77.21M
+16.2% YoY
|
| EBITDA |
-4.37M
est: -12.82M (+65.9%)
|
-3.79M
est: -15.83M (+76.0%)
|
-13.01M
est: -16.01M (+18.8%)
|
-13.92M
est: -7.17M (-94.2%)
|
-19.07M
est: -11.88M (-60.6%)
|
-18.48M
est: -11.36M (-62.7%)
|
-13.91M
est: -19.85M (+30.0%)
|
-22.01M
est: -19.22M (-14.5%)
|
-18.11M
est: -15.55M (-16.5%)
|
-16.80M
est: -15.00M (-12.0%)
|
-5.79M
est: -16.56M (+65.0%)
|
-18.89M
-19.09M – -18.61M
-14.1% YoY
|
-20.86M
-21.08M – -20.54M
-10.4% YoY
|
-24.23M
-24.49M – -23.87M
-16.2% YoY
|
| EBIT |
-5.19M
est: -13.39M (+61.3%)
|
-3.73M
est: -16.54M (+77.5%)
|
-13.70M
est: -16.73M (+18.1%)
|
-14.59M
est: -7.49M (-94.8%)
|
-19.83M
est: -12.41M (-59.8%)
|
-19.36M
est: -11.87M (-63.1%)
|
-14.81M
est: -20.75M (+28.6%)
|
-22.90M
est: -20.08M (-14.0%)
|
-18.80M
est: -16.30M (-15.3%)
|
-17.40M
est: -15.72M (-10.7%)
|
-6.45M
est: -17.37M (+62.9%)
|
-19.81M
-20.02M – -19.51M
-14.1% YoY
|
-21.87M
-22.10M – -21.54M
-10.4% YoY
|
-25.40M
-25.67M – -25.02M
-16.2% YoY
|
| Net Income |
-5.37M
est: -9.77M (+45.1%)
|
-3.95M
est: -3.44M (-15.0%)
|
-5.06M
est: -6.40M (+20.9%)
|
64.01M
est: 66.46M (-3.7%)
|
-19.71M
est: -21.15M (+6.8%)
|
-11.90M
est: -14.66M (+18.9%)
|
-15.17M
est: -17.59M (+13.8%)
|
-23.18M
est: -22.94M (-1.1%)
|
-18.71M
est: -34.43M (+45.6%)
|
-23.46M
est: -29.66M (+20.9%)
|
-11.21M
est: -12.76M (+12.1%)
|
-11.77M
-11.97M – -11.57M
+7.7% YoY
|
-11.04M
-11.22M – -10.85M
+6.2% YoY
|
-4.62M
-4.70M – -4.55M
+58.1% YoY
|
| SGA |
17.38M
est: 30.07M (-42.2%)
|
19.09M
est: 37.13M (-48.6%)
|
21.05M
est: 37.56M (-44.0%)
|
21.18M
est: 16.81M (+26.0%)
|
36.23M
est: 27.87M (+30.0%)
|
33.67M
est: 26.65M (+26.3%)
|
43.73M
est: 46.58M (-6.1%)
|
48.15M
est: 45.09M (+6.8%)
|
48.87M
est: 44.09M (+10.8%)
|
43.13M
est: 42.52M (+1.4%)
|
36.12M
est: 46.96M (-23.1%)
|
53.57M
52.76M – 54.14M
+14.1% YoY
|
59.14M
58.24M – 59.76M
+10.4% YoY
|
68.71M
67.67M – 69.44M
+16.2% YoY
|
| EPS |
-0.22
est: -0.28 (+20.0%)
|
-0.14
est: -0.10 (-44.8%)
|
-0.16
est: -0.18 (+11.1%)
|
1.93
est: 1.87 (+3.2%)
|
-0.58
est: -0.60 (+2.5%)
|
-0.35
est: -0.41 (+15.2%)
|
-0.44
est: -0.50 (+11.1%)
|
-0.67
est: -0.64 (-4.7%)
|
-0.54
est: -0.82 (+34.1%)
|
-0.66
est: -0.71 (+6.4%)
|
-0.27
est: -0.30 (+11.0%)
|
-0.28
-0.28 – -0.27
+7.7% YoY
|
-0.26
-0.27 – -0.26
+6.3% YoY
|
-0.11
-0.11 – -0.11
+58.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-8.33M
OE per share TTM
-0.21
Owner's Yield
-5.55%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
16.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
13.15M
Insider transactions (90d)
0
Beneficial owners (>5%)
26
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RTW Investments, LP | 3.40M | 9.90% | — | 3.40M | — | — | IA, PN | Delaware | 2022-02-14 | ↗ |
| 2 | Roderick Wong | 3.40M | 9.90% | — | 3.40M | — | — | HC, IN | Delaware | 2022-02-14 | ↗ |
| 3 | S | 3.39M | 9.93% | — | 3.39M | — | — | HC | — | 2020-02-14 | ↗ |
| 4 | William Weeks Vanderfelt | 3.16M | 9.20% | 3.16M | — | 3.16M | — | IN | United Kingdom | 2020-01-09 | ↗ |
| 5 | Archon Capital Management LLC | 3.12M | 8.99% | — | — | — | 3.12M | IA, OO | DELAWARE | 2024-10-31 | ↗ |
| 6 | Constantinos Christofilis | 3.12M | 8.99% | — | — | — | 3.12M | HC, IN | DELAWARE | 2024-10-31 | ↗ |
| 7 | RTW Master Fund, Ltd. | 2.58M | 7.52% | — | 2.58M | — | 2.58M | CO | OR PLACE OF ORGANIZATION | 2021-02-12 | ↗ |
| 8 | Efrem Kamen | 2.50M | 7.21% | — | 2.50M | — | 2.50M | HC, IN | Delaware | 2022-11-23 | ↗ |
| 9 | Pura Vida Investments, LLC | 2.50M | 7.21% | — | 2.50M | — | 2.50M | IA | Delaware | 2022-11-23 | ↗ |
| 10 | 52-2343049 | 2.16M | 6.23% | 2.16M | — | 2.16M | — | IA | New York | 2024-01-23 | ↗ |
| 11 | Divisadero Street Capital Management, LP | 2.06M | 11.00% | — | 2.06M | — | 2.06M | IA, PN | U.S.A | 2023-05-19 | ↗ |
| 12 | Divisadero Street Partners GP, LLC | 2.06M | 11.00% | — | 2.06M | — | 2.06M | HC, OO | U.S.A | 2023-05-19 | ↗ |
| 13 | Divisadero Street Partners, L.P. | 2.06M | 11.00% | — | 2.06M | — | 2.06M | PN | U.S.A | 2023-05-19 | ↗ |
| 14 | William Zolezzi | 2.06M | 11.00% | — | 2.06M | — | 2.06M | HC, IN | U.S.A | 2023-05-19 | ↗ |
| 15 | 27-4413262 | 1.88M | 5.40% | 1.88M | — | 1.88M | — | OO | Maryland | 2023-08-14 | ↗ |
| 16 | Identification Nos. of above persons (. | 1.88M | 5.40% | 1.88M | — | 1.88M | — | IN | States | 2023-08-14 | ↗ |
| 17 | Pura Vida Master Fund, Ltd. | 1.81M | 5.23% | — | 1.81M | — | 1.81M | OO | Delaware | 2022-11-23 | ↗ |
| 18 | Strategos Fund, L.P. | 1.79M | 5.18% | — | — | — | 1.79M | PN | DELAWARE | 2024-10-31 | ↗ |
| 19 | Stavros G. Vizirgianakis | 1.75M | 5.04% | 1.75M | — | 1.75M | — | IN | — | 2024-04-01 | ↗ |
| 20 | Strategos Master Fund GP LLC | 1.32M | 3.81% | — | — | — | 1.32M | OO | DELAWARE | 2024-10-31 | ↗ |
| 21 | Strategos Master Fund, L.P. | 1.32M | 3.81% | — | — | — | 1.32M | PN | DELAWARE | 2024-10-31 | ↗ |
| 22 | 56-2450074 | 1.01M | 3.28% | 647.6K | — | 647.6K | — | IA | Wisconsin | 2017-04-10 | ↗ |
| 23 | (1) BlackRock, Inc. | 524.7K | 1.50% | 522.2K | — | 524.7K | — | HC | Delaware | 2022-07-08 | ↗ |
| 24 | Dr. Jeffrey R. Jay, M.D. | — | 0.00% | — | — | — | — | IN | USA | 2018-02-14 | ↗ |
| 25 | Great Point Partners, LLC | — | 0.00% | — | — | — | — | IA | USA | 2018-02-14 | ↗ |
| 26 | Mr. David Kroin | — | 0.00% | — | — | — | — | IN | USA | 2018-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
10
-52 vs prev Q
New positions
0
Closed positions
48
Increased
2
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NANTAHALA CAPITAL MANAGEMENT, LLC | 3.97M +636.0K (+19.1%) | 13.91M +6.8M (+94.7%) | 9.76% +1.562 pp | 0.46% +0.212 pp | USD1.90 +84.2% | 5 qtrs — |
| 2 | ARCHON CAPITAL MANAGEMENT LLC | 3.21M -68.3K (-2.1%) | 11.25M +4.2M (+60.1%) | 7.89% -0.168 pp | 6.40% +2.216 pp | USD5.54 -36.8% | 28 qtrs — |
| 3 | ROYCE & ASSOCIATES LP | 2.44M -31.4K (-1.3%) | 8.55M +3.3M (+61.5%) | 6.00% -0.077 pp | 0.09% +0.034 pp | USD3.51 -0.3% | 28 qtrs — |
| 4 | VANGUARD GROUP INC | 1.57M +36.1K (+2.4%) | 5.48M +2.2M (+67.4%) | 3.84% +0.089 pp | 0.00% +0.000 pp | USD6.78 -48.4% | 28 qtrs — |
| 5 | AIGH CAPITAL MANAGEMENT LLC | 1.10M +1.1M (+100.0%) | 3.87M +3.9M (+100.0%) | 2.71% +2.713 pp | 0.94% +0.936 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 6 | SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 1.03M +46.5K (+4.7%) | 3.62M +1.5M (+71.3%) | 2.54% +0.114 pp | 2.09% +0.807 pp | USD2.43 +44.0% | 9 qtrs — |
| 7 | COMMONWEALTH EQUITY SERVICES, LLC | 663.5K +— (+0.0%) | 2.32M +902.4K (+63.5%) | 1.63% +0.000 pp | 0.00% +0.001 pp | USD1.48 +136.5% | 8 qtrs — |
| 8 | HORIZON KINETICS ASSET MANAGEMENT LLC | 615.0K +— (+0.0%) | 2.15M +836.4K (+63.6%) | 1.51% +0.000 pp | 0.03% +0.013 pp | USD6.95 -49.6% | 28 qtrs — |
| 9 | BLACKROCK, INC. | 511.0K +1.2K (+0.2%) | 1.79M +697.5K (+63.9%) | 1.25% +0.003 pp | 0.00% +0.000 pp | USD1.27 +175.6% | 6 qtrs — |
| 10 | TAYLOR FRIGON CAPITAL MANAGEMENT LLC | 438.0K -32.7K (-6.9%) | 1.53M +525.7K (+52.2%) | 1.08% -0.080 pp | 0.78% +0.275 pp | USD4.68 -25.2% | 28 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 358.8K +7.6K (+2.1%) | 1.26M +504.8K (+67.1%) | 0.88% +0.019 pp | 0.00% +0.000 pp | USD5.97 -41.4% | 28 qtrs — |
| 12 | EAM INVESTORS, LLC | 246.4K +246.4K (+100.0%) | 862.5K +862.5K (+100.0%) | 0.61% +0.605 pp | 0.10% +0.096 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 13 | HUNTLEIGH ADVISORS, INC. | 236.4K +236.4K (+100.0%) | 827.4K +827.4K (+100.0%) | 0.58% +0.580 pp | 0.14% +0.140 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 220.4K -1.3K (-0.6%) | 771.4K +297.0K (+62.6%) | 0.54% -0.003 pp | 0.00% +0.001 pp | USD5.06 -30.8% | 28 qtrs — |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 201.7K +201.7K (+100.0%) | 705.8K +705.8K (+100.0%) | 0.50% +0.495 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 16 | KINGSVIEW WEALTH MANAGEMENT, LLC | 188.2K -4.9K (-2.5%) | 658.7K +245.6K (+59.4%) | 0.46% -0.012 pp | 0.01% +0.003 pp | USD1.48 +136.5% | 12 qtrs — |
| 17 | SEI INVESTMENTS CO | 150.1K +150.1K (+100.0%) | 525.3K +525.3K (+100.0%) | 0.37% +0.369 pp | 0.00% +0.001 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 18 | 683 CAPITAL MANAGEMENT, LLC | 124.5K +124.5K (+100.0%) | 435.8K +435.8K (+100.0%) | 0.31% +0.306 pp | 0.02% +0.019 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 19 | STATE STREET CORP | 116.7K +7.4K (+6.8%) | 408.5K +174.6K (+74.6%) | 0.29% +0.018 pp | 0.00% +0.000 pp | USD6.84 -48.8% | 28 qtrs — |
| 20 | MARSHALL WACE, LLP | 107.9K +107.9K (+100.0%) | 377.6K +377.6K (+100.0%) | 0.26% +0.265 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 21 | NORTHERN TRUST CORP | 105.6K -1.2K (-1.1%) | 369.7K +141.2K (+61.8%) | 0.26% -0.003 pp | 0.00% +0.000 pp | USD4.22 -17.1% | 28 qtrs — |
| 22 | HILLSDALE INVESTMENT MANAGEMENT INC. | 94.5K +94.5K (+100.0%) | 330.8K +330.8K (+100.0%) | 0.23% +0.232 pp | 0.01% +0.009 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 23 | QUBE RESEARCH & TECHNOLOGIES LTD | 93.7K +93.7K (+100.0%) | 327.9K +327.9K (+100.0%) | 0.23% +0.230 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 24 | GOLDMAN SACHS GROUP INC | 92.7K +74.7K (+415.1%) | 324.5K +285.9K (+742.5%) | 0.23% +0.183 pp | 0.00% +0.000 pp | USD3.24 +8.0% | 2 qtrs — |
| 25 | MILLENNIUM MANAGEMENT LLC | 92.7K +92.7K (+100.0%) | 324.4K +324.4K (+100.0%) | 0.23% +0.228 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 26 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 87.1K +87.1K (+100.0%) | 304.9K +304.9K (+100.0%) | 0.21% +0.214 pp | 0.00% +0.002 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 27 | PERKINS CAPITAL MANAGEMENT INC | 85.0K +4.0K (+4.9%) | 297.5K +124.2K (+71.6%) | 0.21% +0.010 pp | 0.24% +0.084 pp | USD2.94 +19.0% | 16 qtrs — |
| 28 | RPG FAMILY WEALTH ADVISORY, LLC | 76.3K +— (+0.0%) | 266.9K +103.7K (+63.6%) | 0.19% +0.000 pp | 0.06% +0.023 pp | USD2.14 +63.6% | 2 qtrs — |
| 29 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61.6K +— (+0.0%) | 215.6K +83.8K (+63.6%) | 0.15% +0.000 pp | 0.00% +0.002 pp | USD3.16 +10.8% | 14 qtrs — |
| 30 | CAPTION MANAGEMENT, LLC | 60.1K -700.0 (-1.2%) | 210.4K +80.2K (+61.7%) | 0.15% -0.002 pp | 0.00% +0.000 pp | USD2.14 +63.6% | 2 qtrs — |
| 31 | SALEM INVESTMENT COUNSELORS INC | 45.5K +— (+0.0%) | 159.3K +61.9K (+63.6%) | 0.11% +0.000 pp | 0.00% +0.002 pp | USD2.14 +63.6% | 2 qtrs — |
| 32 | ACADIAN ASSET MANAGEMENT LLC | 38.8K +38.8K (+100.0%) | 131.0K +131.0K (+100.0%) | 0.10% +0.095 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 33 | OMERS ADMINISTRATION CORP | 31.7K +31.7K (+100.0%) | 111.0K +111.0K (+100.0%) | 0.08% +0.078 pp | 0.00% +0.001 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 34 | FRANKLIN RESOURCES INC | 25.9K -1.5K (-5.6%) | 90.8K +32.0K (+54.3%) | 0.06% -0.004 pp | 0.00% +0.000 pp | USD2.14 +63.6% | 2 qtrs — |
| 35 | MORGAN STANLEY | 24.1K +10.4K (+76.1%) | 84.2K +55.0K (+188.1%) | 0.06% +0.026 pp | 0.00% +0.000 pp | USD3.16 +10.8% | 28 qtrs — |
| 36 | GREENWOOD CAPITAL ASSOCIATES LLC | 22.8K +— (+0.0%) | 79.8K +31.0K (+63.6%) | 0.06% +0.000 pp | 0.01% +0.003 pp | USD6.66 -47.4% | 18 qtrs — |
| 37 | POINT72 ASSET MANAGEMENT, L.P. | 22.2K +22.2K (+100.0%) | 77.7K +77.7K (+100.0%) | 0.05% +0.055 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 38 | CITIGROUP INC | 21.6K +21.6K (+100.0%) | 75.7K +75.7K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 39 | HUDSON BAY CAPITAL MANAGEMENT LP | 20.7K +20.7K (+100.0%) | 72.5K +72.5K (+100.0%) | 0.05% +0.051 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 40 | JOEL ISAACSON & CO., LLC | 20.5K +— (+0.0%) | 71.8K +27.9K (+63.6%) | 0.05% +0.000 pp | 0.00% +0.001 pp | USD1.37 +155.5% | 4 qtrs — |
| 41 | SCHOLTZ & COMPANY, LLC | 20.0K +— (+0.0%) | 70.0K +27.2K (+63.6%) | 0.05% +0.000 pp | 0.03% +0.012 pp | USD3.50 +0.0% | 12 qtrs — |
| 42 | BANK OF AMERICA CORP /DE/ | 17.7K +35.0 (+0.2%) | 61.9K +24.1K (+63.9%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD3.78 -7.4% | 28 qtrs — |
| 43 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 17.0K +17.0K (+100.0%) | 59.6K +59.6K (+100.0%) | 0.04% +0.042 pp | 0.00% +0.002 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 44 | CREATIVE PLANNING | 16.9K +16.9K (+100.0%) | 59.2K +59.2K (+100.0%) | 0.04% +0.042 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 45 | GROUP ONE TRADING, L.P. | 11.4K +9.7K (+538.6%) | 40.1K +36.2K (+944.4%) | 0.03% +0.024 pp | 0.00% +0.000 pp | USD3.29 +6.4% | 10 qtrs — |
| 46 | LEDGEWOOD WEALTH ADVISORS, LLC | 10.0K +— (+0.0%) | 35.0K +13.6K (+63.6%) | 0.02% +0.000 pp | 0.02% +0.008 pp | USD2.62 +33.6% | 9 qtrs — |
| 47 | SIMPLEX TRADING, LLC | 9.9K +5.3K (+116.6%) | 34.8K +25.8K (+286.3%) | 0.02% +0.013 pp | 0.00% +0.000 pp | USD2.89 +21.1% | 9 qtrs — |
| 48 | ADVISOR GROUP HOLDINGS, INC. | 8.4K +900.0 (+12.0%) | 29.4K +13.1K (+79.8%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD2.38 +47.1% | 3 qtrs — |
| 49 | HIGHMARK WEALTH MANAGEMENT LLC | 5.0K +— (+0.0%) | 17.5K +6.8K (+63.6%) | 0.01% +0.000 pp | 0.01% +0.002 pp | USD2.62 +33.6% | 9 qtrs — |
| 50 | ROYAL BANK OF CANADA | 4.0K -3.3K (-45.2%) | 14.0K -2.0K (-12.5%) | 0.01% -0.008 pp | 0.00% +0.000 pp | USD2.61 +34.1% | 10 qtrs — |
| 51 | WELLS FARGO & COMPANY/MN | 1.5K +1.5K (+100.0%) | 5.3K +5.3K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD3.50 +0.0% | 1 qtrs NEW |
| 52 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.5K -2.3K (-60.8%) | 5.1K -2.9K (-35.9%) | 0.00% -0.006 pp | 0.00% 0.000 pp | USD2.14 +63.6% | 11 qtrs — |
| 53 | UBS GROUP AG | 1.4K -11.3K (-88.8%) | 5.0K -22.2K (-81.6%) | 0.00% -0.028 pp | 0.00% +0.000 pp | USD2.12 +65.1% | 28 qtrs — |
| 54 | TRUST CO OF TOLEDO NA /OH/ | 1.0K +— (+0.0%) | 3.5K +1.4K (+63.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.25 +55.6% | 3 qtrs — |
| 55 | JONES FINANCIAL COMPANIES LLLP | 400.00 +— (+0.0%) | 1.4K +592.0 (+73.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.37 +155.5% | 4 qtrs — |
| 56 | BNP PARIBAS ARBITRAGE, SNC | 15.00 +— (+0.0%) | 52.00 +20.0 (+62.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.20 +9.4% | 10 qtrs — |
| 57 | SBI SECURITIES CO., LTD. | 10.00 +— (+0.0%) | 35.00 +14.0 (+66.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.90 +84.2% | 5 qtrs — |
| 58 | DIMENSIONAL FUND ADVISORS LP | — -24.7K (-100.0%) | — -52.8K (-100.0%) | 0.00% -0.061 pp | 0.00% +0.000 pp | USD— | 28 qtrs SOLD |
| 59 | LARSON FINANCIAL GROUP LLC | — -6.0K (-100.0%) | — -12.8K (-100.0%) | 0.00% -0.015 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 60 | XTX TOPCO LTD | — -21.5K (-100.0%) | — -46.1K (-100.0%) | 0.00% -0.053 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 61 | CAPROCK GROUP, LLC | — -19.9K (-100.0%) | — -39.6K (-100.0%) | 0.00% -0.049 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 62 | JANE STREET GROUP, LLC | — -23.6K (-100.0%) | — -50.5K (-100.0%) | 0.00% -0.058 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 63 | PRIVATE ADVISOR GROUP, LLC | — -66.7K (-100.0%) | — -142.8K (-100.0%) | 0.00% -0.164 pp | 0.00% -0.001 pp | USD— | 7 qtrs SOLD |
| 64 | PERCEPTIVE ADVISORS LLC | — -150.0K (-100.0%) | — -321.0K (-100.0%) | 0.00% -0.368 pp | 0.00% -0.009 pp | USD— | 5 qtrs SOLD |
| 65 | GREY FOX WEALTH ADVISORS, LLC | — -2.0K (-100.0%) | — -4.3K (-100.0%) | 0.00% -0.005 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 66 | CITADEL ADVISORS LLC | — -13.3K (-100.0%) | — -28.4K (-100.0%) | 0.00% -0.033 pp | 0.00% +0.000 pp | USD— | 20 qtrs SOLD |
| 67 | AMERITAS ADVISORY SERVICES, LLC | — -100.0 (-100.0%) | — -214.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 13 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.04% | 535.6K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 1.56M | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 9.3K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.9K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 25.5K | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 4.35M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 9.5K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 5.2K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 2.1K | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 231.21 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.00
Neutral
Buys
2
Sells
2
Shares acquired
49.0K
Shares disposed
49.0K
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-15 | CITRONOWICZ MOSHE | Officer | M-Exempt | A | Common Stock | 37,000 | 1.80 | 66.6K | 493,504 | D | ↗ |
| 2026-01-27 | Roman Shawn David | Officer | M-Exempt | A | Common Stock | 12,000 | 1.80 | 21.6K | 12,000 | I | ↗ |
| 2025-05-15 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 30,000 | 1.48 | 44.4K | 30,000 | D | ↗ |
| 2025-05-15 | Vizirgianakis Stavros G. | Director | A-Award | A | Stock Option (Option to Buy) | 128,000 | 1.48 | 189.4K | 128,000 | D | ↗ |
| 2025-05-15 | Levine Wendy Lauren | Director | A-Award | A | Stock Option (Option to Buy) | 64,000 | 1.48 | 94.7K | 64,000 | D | ↗ |
| 2025-05-15 | HILL MATTHEW C | Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 1.48 | 148.0K | 100,000 | D | ↗ |
| 2025-05-15 | Goodwin Charles D. II | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 193,000 | 1.48 | 285.6K | 193,000 | D | ↗ |
| 2025-05-15 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 36,000 | 1.48 | 53.3K | 36,000 | D | ↗ |
| 2025-05-15 | Baylor-Henry Minnie | Director | A-Award | A | Stock Option (Option to Buy) | 59,000 | 1.48 | 87.3K | 59,000 | D | ↗ |
| 2025-01-15 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 50,000 | 1.42 | 71.0K | 50,000 | D | ↗ |
| 2025-01-15 | Vizirgianakis Stavros G. | Director | A-Award | A | Stock Option (Option to Buy) | 50,000 | 1.42 | 71.0K | 50,000 | D | ↗ |
| 2025-01-15 | Roman Shawn David | Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 1.42 | 142.0K | 100,000 | D | ↗ |
| 2025-01-15 | Levine Wendy Lauren | Director | A-Award | A | Stock Option (Option to Buy) | 50,000 | 1.42 | 71.0K | 50,000 | D | ↗ |
| 2025-01-15 | HILL MATTHEW C | Officer | A-Award | A | Stock Option (Option to Buy) | 50,000 | 1.42 | 71.0K | 50,000 | D | ↗ |
| 2025-01-15 | Goodwin Charles D. II | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 50,000 | 1.42 | 71.0K | 50,000 | D | ↗ |
| 2025-01-15 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 36,000 | 1.42 | 51.1K | 36,000 | D | ↗ |
| 2025-01-15 | Baylor-Henry Minnie | Director | A-Award | A | Stock Option (Option to Buy) | 50,000 | 1.42 | 71.0K | 50,000 | D | ↗ |
| 2024-11-06 | Roman Shawn David | Officer | — | — | Employee Stock Option (right to buy) | 12,000 | 1.80 | 21.6K | 0 | D | ↗ |
| 2024-08-13 | HILL MATTHEW C | Officer | P-Purchase | A | Common Stock | 6,000 | 1.13 | 6.8K | 8,500 | D | ↗ |
| 2024-08-08 | Waldman Lawrence | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-08-08 | Vizirgianakis Stavros G. | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-08-08 | Swandal Craig A. | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-08-08 | Levine Wendy Lauren | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-08-08 | Geraghty Michael | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-08-08 | Baylor-Henry Minnie | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-08-08 | Andres John C. | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 1.02 | 17.3K | 17,000 | — | ↗ |
| 2024-05-07 | Vizirgianakis Stavros G. | Director | — | D | Common Stock | 0 | 0.00 | — | 1,746,191 | — | ↗ |
| 2024-01-10 | Hornsby Todd | Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 2.42 | 242.0K | 0 | — | ↗ |
| 2024-01-10 | HILL MATTHEW C | Officer | A-Award | A | Stock Option (Option to Buy) | 150,000 | 2.42 | 363.0K | 0 | — | ↗ |
| 2024-01-10 | Goodwin Charles D. II | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 243,000 | 2.42 | 588.1K | 0 | — | ↗ |
| 2024-01-10 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 72,000 | 2.42 | 174.2K | 0 | — | ↗ |
| 2023-12-12 | HILL MATTHEW C | Officer | P-Purchase | A | Common Stock | 2,500 | 2.19 | 5.5K | 2,500 | — | ↗ |
| 2023-12-04 | HILL MATTHEW C | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-11-14 | Goodwin Charles D. II | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 1.57 | 78.5K | 90,000 | — | ↗ |
| 2023-08-10 | Waldman Lawrence | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-08-10 | Swandal Craig A. | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-08-10 | MAKRIDES ANDREW | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-08-10 | Levine Wendy Lauren | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-08-10 | Geraghty Michael | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-08-10 | Baylor-Henry Minnie | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-08-10 | Andres John C. | Director | A-Award | D | Stock Option (Option to Buy) | 17,000 | 4.25 | 72.3K | 17,000 | — | ↗ |
| 2023-07-12 | Waldman Lawrence | Director | M-Exempt | A | Common Stock | 5,338 | 2.97 | 15.9K | 5,338 | — | ↗ |
| 2023-06-26 | Hornsby Todd | Officer | M-Exempt | D | Stock Option (Option to Buy) | 15,000 | 1.77 | 26.6K | 20,000 | D | ↗ |
| 2023-06-06 | Geraghty Michael | Director | M-Exempt | A | Common Stock | 10,000 | 2.79 | 27.9K | 27,500 | — | ↗ |
| 2023-01-11 | Semb Tara | Officer | A-Award | A | Stock Option (Option to Buy) | 96,000 | 0.00 | — | 96,000 | — | ↗ |
| 2023-01-11 | Hornsby Todd | Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2023-01-11 | Goodwin Charles D. II | Officer | A-Award | A | Stock Option (Option to Buy) | 243,000 | 0.00 | — | 243,000 | — | ↗ |
| 2023-01-11 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 72,000 | 0.00 | — | 72,000 | — | ↗ |
| 2022-08-29 | Goodwin Charles D. II | Officer | P-Purchase | A | Common Stock | 9,750 | 5.97 | 58.2K | 40,000 | — | ↗ |
| 2022-08-25 | Levine Wendy Lauren | Director | — | D | Stock Option (Option to Buy) | 17,000 | 11.51 | 195.7K | 0 | — | ↗ |
| 2022-08-11 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 0.00 | — | 17,000 | — | ↗ |
| 2022-08-11 | Swandal Craig A. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 10.28 | 174.8K | 17,000 | — | ↗ |
| 2022-08-11 | MAKRIDES ANDREW | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 0.00 | — | 17,000 | — | ↗ |
| 2022-08-11 | Levine Wendy Lauren | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 0.00 | — | 17,000 | — | ↗ |
| 2022-08-11 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 0.00 | — | 17,000 | — | ↗ |
| 2022-08-11 | Baylor-Henry Minnie | Director | A-Award | A | Stock Option (Option to Buy) | 37,000 | 0.00 | — | 37,000 | — | ↗ |
| 2022-08-11 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 0.00 | — | 17,000 | — | ↗ |
| 2022-07-11 | Waldman Lawrence | Director | M-Exempt | D | Stock Option (Option to Buy) | 24,000 | 2.54 | 61.0K | 0 | — | ↗ |
| 2022-07-11 | CITRONOWICZ MOSHE | Officer | M-Exempt | D | Stock Option (Option to Buy) | 30,000 | 2.54 | 76.2K | 0 | — | ↗ |
| 2022-07-06 | Geraghty Michael | Director | M-Exempt | D | Stock Option (Option to Buy) | 4,000 | 0.00 | — | 0 | — | ↗ |
| 2022-07-05 | MAKRIDES ANDREW | Director | M-Exempt | A | Common Stock | 30,000 | 2.54 | 76.2K | 637,972 | — | ↗ |
| 2022-05-19 | Waldman Lawrence | Director | M-Exempt | A | Common Stock | 8,000 | 2.79 | 22.3K | 13,563 | — | ↗ |
| 2022-05-11 | Geraghty Michael | Director | M-Exempt | D | Stock Option (Option to Buy) | 6,000 | 2.79 | 16.7K | 0 | — | ↗ |
| 2022-03-21 | Swandal Craig A. | Director | M-Exempt | A | Common Stock | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2022-01-19 | Semb Tara | Officer | A-Award | A | Stock Option (Option to Buy) | 96,000 | 10.96 | 1.05M | 96,000 | — | ↗ |
| 2022-01-19 | Hornsby Todd | Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 10.96 | 1.10M | 100,000 | — | ↗ |
| 2022-01-19 | Goodwin Charles D. II | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 243,000 | 10.96 | 2.66M | 243,000 | — | ↗ |
| 2022-01-19 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 72,000 | 10.96 | 789.1K | 72,000 | — | ↗ |
| 2022-01-07 | Swandal Craig A. | Director | M-Exempt | D | Stock Option (Option to Buy) | 7,173 | 9.42 | 67.6K | 0 | — | ↗ |
| 2021-08-06 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 9.42 | 160.1K | 17,000 | — | ↗ |
| 2021-08-06 | Swandal Craig A. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 9.42 | 160.1K | 17,000 | — | ↗ |
| 2021-08-06 | MAKRIDES ANDREW | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 9.42 | 160.1K | 17,000 | — | ↗ |
| 2021-08-06 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 9.42 | 160.1K | 17,000 | — | ↗ |
| 2021-08-06 | Baylor-Henry Minnie | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 9.42 | 160.1K | 17,000 | — | ↗ |
| 2021-08-06 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 9.42 | 160.1K | 17,000 | — | ↗ |
| 2021-03-08 | Waldman Lawrence | Director | M-Exempt | A | Common Stock | 5,563 | 2.81 | 15.6K | 5,563 | — | ↗ |
| 2021-03-05 | Geraghty Michael | Director | M-Exempt | A | Common Stock | 7,500 | 2.81 | 21.1K | 7,500 | — | ↗ |
| 2021-01-29 | Semb Tara | Officer | A-Award | A | Stock Option (Option to Buy) | 48,000 | 9.29 | 445.9K | 48,000 | — | ↗ |
| 2021-01-29 | Hornsby Todd | Officer | A-Award | A | Stock Option (Option to Buy) | 50,000 | 9.29 | 464.5K | 50,000 | — | ↗ |
| 2021-01-29 | Goodwin Charles D. II | Director / Officer | A-Award | A | Common Stock | 121,500 | 9.29 | 1.13M | 121,500 | — | ↗ |
| 2021-01-29 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 36,000 | 9.29 | 334.4K | 36,000 | — | ↗ |
| 2020-10-07 | Swandal Craig A. | Director | M-Exempt | D | Stock Option (Option to Buy) | 7,084 | 7.28 | 51.6K | 0 | — | ↗ |
| 2020-08-06 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2020-08-06 | Swandal Craig A. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2020-08-06 | MAKRIDES ANDREW | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2020-08-06 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2020-08-06 | Baylor-Henry Minnie | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2020-08-06 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 4.98 | 84.7K | 17,000 | — | ↗ |
| 2020-08-01 | Baylor-Henry Minnie | Director | — | D | Stock Option (Option to Buy) | 17,000 | 7.28 | 123.8K | 0 | — | ↗ |
| 2020-05-13 | Goodwin Charles D. II | Director / Officer | P-Purchase | A | Common Stock | 28,250 | 3.30 | 93.2K | 28,250 | — | ↗ |
| 2020-01-15 | Semb Tara | Officer | A-Award | A | Stock Option (Option to Buy) | 96,000 | 8.18 | 785.3K | 96,000 | — | ↗ |
| 2020-01-15 | Hornsby Todd | Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 8.18 | 818.0K | 100,000 | — | ↗ |
| 2020-01-15 | Goodwin Charles D. II | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 243,000 | 8.18 | 1.99M | 243,000 | — | ↗ |
| 2020-01-15 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 72,000 | 8.18 | 589.0K | 72,000 | — | ↗ |
| 2019-12-14 | Goodwin Charles D. II | Director / Officer | — | D | Stock Option (Option to Buy) | 1,000,000 | 2.99 | 2.99M | 0 | — | ↗ |
| 2019-10-01 | Swandal Craig A. | Director | X-InTheMoney | A | Common Stock | 10,000 | 5.30 | 53.0K | 36,000 | — | ↗ |
| 2019-08-01 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 7.28 | 123.8K | 17,000 | — | ↗ |
| 2019-08-01 | Swandal Craig A. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 7.28 | 123.8K | 17,000 | — | ↗ |
| 2019-08-01 | MAKRIDES ANDREW | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 7.28 | 123.8K | 17,000 | — | ↗ |
| 2019-08-01 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 7.28 | 123.8K | 17,000 | — | ↗ |
| 2019-08-01 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 17,000 | 7.28 | 123.8K | 17,000 | — | ↗ |
| 2019-04-04 | Swandal Craig A. | Director | O-OutOfTheMoney | A | Common Stock | 6,000 | 5.30 | 31.8K | 26,000 | — | ↗ |
| 2019-03-09 | Swandal Craig A. | Director | — | D | Stock Option (Option to Buy) | 12,000 | 2.37 | 28.4K | 0 | — | ↗ |
| 2019-01-10 | Swandal Craig A. | Director | X-InTheMoney | D | Stock Option (Option to Buy) | 10,000 | 2.37 | 23.7K | 2,000 | — | ↗ |
| 2019-01-09 | Semb Tara | Officer | A-Award | A | Stock Option (Option to Buy) | 65,000 | 7.91 | 514.2K | 65,000 | — | ↗ |
| 2019-01-09 | Hornsby Todd | Officer | A-Award | A | Stock Option (Option to Buy) | 76,000 | 7.91 | 601.2K | 76,000 | — | ↗ |
| 2019-01-09 | Goodwin Charles D. II | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 236,000 | 7.91 | 1.87M | 236,000 | — | ↗ |
| 2019-01-09 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 72,000 | 7.91 | 569.5K | 72,000 | — | ↗ |
| 2019-01-06 | Hornsby Todd | Officer | — | D | Common Stock | 0 | 0.00 | — | 40 | — | ↗ |
| 2019-01-02 | Semb Tara | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-12-15 | Hornsby Todd | Officer | — | D | Stock Option (Option to Buy) | 100,000 | 2.99 | 299.0K | 0 | — | ↗ |
| 2018-11-08 | MAKRIDES ANDREW | Director | G-Gift | D | Common Stock | 2,000 | 6.84 | 13.7K | 609,972 | — | ↗ |
| 2018-08-30 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 24,000 | 5.30 | 127.2K | 24,000 | — | ↗ |
| 2018-08-30 | Swandal Craig A. | Director | A-Award | A | Stock Option (Option to Buy) | 24,000 | 5.30 | 127.2K | 24,000 | — | ↗ |
| 2018-08-30 | MAKRIDES ANDREW | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 5.30 | 63.6K | 12,000 | — | ↗ |
| 2018-08-30 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 24,000 | 5.30 | 127.2K | 24,000 | — | ↗ |
| 2018-08-30 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 24,000 | 5.30 | 127.2K | 24,000 | — | ↗ |
| 2018-05-01 | Hornsby Todd | Officer | — | D | Stock Option (Option to Buy) | 15,000 | 2.23 | 33.5K | 0 | — | ↗ |
| 2018-01-04 | Ewers Jay D. | Officer | A-Award | A | Stock Option (Option to Buy) | 30,000 | 2.59 | 77.7K | 30,000 | — | ↗ |
| 2017-09-14 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 2.85 | 34.2K | 12,000 | — | ↗ |
| 2017-09-14 | MAKRIDES ANDREW | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 2.85 | 34.2K | 12,000 | — | ↗ |
| 2017-09-14 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 2.85 | 34.2K | 12,000 | — | ↗ |
| 2017-09-14 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 2.85 | 34.2K | 12,000 | — | ↗ |
| 2017-05-01 | SARON J ROBERT | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 70,000 | 3.23 | 226.1K | 70,000 | — | ↗ |
| 2017-05-01 | McCarthy John J. III | Officer | A-Award | A | Stock Option (Option to Buy) | 70,000 | 3.23 | 226.1K | 70,000 | — | ↗ |
| 2017-05-01 | Gershon Robert | Director / Officer | A-Award | A | Stock Option (Option to Buy) | 100,000 | 3.23 | 323.0K | 100,000 | — | ↗ |
| 2017-05-01 | Ewers Jay D. | Officer | A-Award | A | Stock Option (Option to Buy) | 70,000 | 3.23 | 226.1K | 70,000 | — | ↗ |
| 2017-05-01 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock Option (Option to Buy) | 70,000 | 3.23 | 226.1K | 70,000 | — | ↗ |
| 2016-08-17 | McCarthy John J. III | Officer | P-Purchase | A | Common Stock | 90,750 | 3.30 | 299.5K | 115,750 | — | ↗ |
| 2016-07-28 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 1.88 | 22.6K | 12,000 | — | ↗ |
| 2016-07-28 | Orsatti Charles T. | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 1.88 | 22.6K | 12,000 | — | ↗ |
| 2016-07-28 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 1.88 | 22.6K | 12,000 | — | ↗ |
| 2016-07-28 | Davidson Scott Richard | Director | — | I | Common Stock Options | 12,000 | 1.88 | 22.6K | 0 | — | ↗ |
| 2016-07-28 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 1.88 | 22.6K | 12,000 | — | ↗ |
| 2015-12-22 | McCarthy John J. III | Officer | P-Purchase | A | Common Stock | 25,000 | 1.98 | 49.4K | 25,000 | — | ↗ |
| 2015-12-21 | Gershon Robert | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 1.82 | 18.2K | 30,000 | — | ↗ |
| 2015-12-21 | CITRONOWICZ MOSHE | Officer | P-Purchase | A | Common Stock | 20,000 | 1.84 | 36.8K | 426,504 | — | ↗ |
| 2015-12-18 | Hornsby Todd | Officer | — | D | Stock Option (Option to Buy) | 35,000 | 1.77 | 62.0K | 0 | — | ↗ |
| 2015-10-14 | Ewers Jay D. | Officer | A-Award | A | Stock Option (Option to Buy) | 65,000 | 2.13 | 138.5K | 65,000 | — | ↗ |
| 2015-08-27 | Hornsby Todd | Officer | — | D | Stock Option (Option to Buy) | 30,000 | 4.30 | 129.0K | 0 | — | ↗ |
| 2015-08-14 | Gershon Robert | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 2.39 | 47.8K | 20,000 | — | ↗ |
| 2015-07-17 | Andres John C. | Director | — | D | Stock Option (option to buy) | 10,000 | 3.81 | 38.1K | 0 | — | ↗ |
| 2015-07-16 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 12,500 | 2.30 | 28.8K | 12,500 | — | ↗ |
| 2015-07-16 | Orsatti Charles T. | Director | A-Award | A | Stock Option (Option to Buy) | 12,500 | 2.30 | 28.8K | 12,500 | — | ↗ |
| 2015-07-16 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 12,500 | 2.30 | 28.8K | 12,500 | — | ↗ |
| 2015-07-16 | Andres John C. | Director | A-Award | A | Stock Option (Option to Buy) | 12,500 | 2.30 | 28.8K | 12,500 | — | ↗ |
| 2015-05-06 | Sheffield Ian | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-05-06 | Orsatti Charles T. | Director | — | D | Stock Option (option to buy) | 100,000 | 2.87 | 287.0K | 0 | — | ↗ |
| 2015-05-05 | Donato Peter | Officer | — | D | Stock Option (option to buy) | 125,000 | 3.81 | 476.3K | 0 | — | ↗ |
| 2015-03-31 | McCarthy John J. III | Officer | — | D | Stock Option (option to buy) | 213,000 | 3.90 | 830.7K | 0 | — | ↗ |
| 2015-03-17 | Sheffield Ian | Director | D-Return | A | Series A Convertible Preferred Stock | 3,500,000 | 0.00 | — | 0 | — | ↗ |
| 2014-12-13 | Gershon Robert | Director / Officer / 10% Owner | — | D | Stock Option (option to buy) | 750,000 | 2.09 | 1.57M | 0 | — | ↗ |
| 2014-09-19 | SARON J ROBERT | Director / Officer | M-Exempt | A | Common Stock | 12,500 | 2.13 | 26.6K | 399,819 | — | ↗ |
| 2014-09-19 | MAKRIDES ANDREW | Director | M-Exempt | A | Common Stock | 25,000 | 2.13 | 53.3K | 624,213 | — | ↗ |
| 2014-09-18 | SARON J ROBERT | Director / Officer | M-Exempt | A | Stock Option (Option to Buy) | 6,379 | 2.13 | 13.6K | 12,500 | — | ↗ |
| 2014-07-17 | Waldman Lawrence | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 3.81 | 45.7K | 12,000 | — | ↗ |
| 2014-07-17 | Sheffield Ian | Director | A-Award | A | Stock Option (Option to Buy) | 12,000 | 3.81 | 45.7K | 12,000 | — | ↗ |
| 2014-07-17 | Geraghty Michael | Director | A-Award | A | Stock Option (Option to Buy) | 10,000 | 3.81 | 38.1K | 10,000 | — | ↗ |
| 2014-06-30 | Ewers Jay D. | Officer | — | D | Stock Option (option to buy) | 35,000 | 3.63 | 127.1K | 0 | — | ↗ |
| 2013-12-13 | Sheffield Ian | Director / 10% Owner | — | I | Common Stock Warrants (right to buy) | 5,250,000 | 2.39 | 12.53M | 0 | — | ↗ |
| 2013-12-09 | Waldman Lawrence | Director | A-Award | A | Stock options | 25,000 | 2.20 | 55.0K | 76,500 | — | ↗ |
| 2013-12-09 | Norman Michael G | Director | A-Award | A | Stock options | 10,000 | 2.20 | 22.0K | 135,000 | — | ↗ |
| 2013-12-09 | Lentricchia August | Director | A-Award | A | Stocks options | 10,000 | 2.20 | 22.0K | 57,500 | — | ↗ |
| 2013-10-01 | KROMER GEORGE W | Director | G-Gift | D | Common stock | 4,000 | 2.91 | 11.6K | 247,508 | — | ↗ |
| 2013-07-16 | Waldman Lawrence | Director | A-Award | A | Stock options | 12,000 | 2.97 | 35.6K | 51,500 | — | ↗ |
| 2013-07-16 | Norman Michael G | Director | A-Award | A | Stock options | 10,000 | 2.97 | 29.7K | 125,000 | — | ↗ |
| 2013-07-16 | Lentricchia August | Director | A-Award | A | Stock options | 10,000 | 2.97 | 29.7K | 43,500 | — | ↗ |
| 2013-07-16 | Geraghty Michael | Director | A-Award | A | Stock options | 10,000 | 2.97 | 29.7K | 27,500 | — | ↗ |
| 2012-12-05 | KROMER GEORGE W | Director | G-Gift | D | Common stock | 5,000 | 2.65 | 13.3K | 251,508 | — | ↗ |
| 2012-09-06 | KROMER GEORGE W | Director | G-Gift | D | Common stock | 5,000 | 2.66 | 13.3K | 256,508 | — | ↗ |
| 2012-07-12 | Waldman Lawrence | Director | A-Award | A | Stock options | 24,000 | 2.54 | 61.0K | 39,500 | — | ↗ |
| 2012-07-12 | SARON J ROBERT | Director / Officer | A-Award | A | Stock options | 30,000 | 2.54 | 76.2K | 67,500 | — | ↗ |
| 2012-07-12 | Pickett Gary | Officer | A-Award | A | Stock options | 10,000 | 2.54 | 25.4K | 57,500 | — | ↗ |
| 2012-07-12 | Norman Michael G | Director | A-Award | A | Stock options | 4,000 | 2.54 | 10.2K | 115,000 | — | ↗ |
| 2012-07-12 | MAKRIDES ANDREW | Director / Officer | A-Award | A | Stock options | 30,000 | 2.54 | 76.2K | 105,000 | — | ↗ |
| 2012-07-12 | Lentricchia August | Director | A-Award | A | Stock options | 4,000 | 2.54 | 10.2K | 37,500 | — | ↗ |
| 2012-07-12 | KROMER GEORGE W | Director | A-Award | A | Stock options | 25,000 | 2.54 | 63.5K | 100,000 | — | ↗ |
| 2012-07-12 | Geraghty Michael | Director | A-Award | A | Stock options | 4,000 | 2.54 | 10.2K | 17,500 | — | ↗ |
| 2012-07-12 | CITRONOWICZ MOSHE | Officer | A-Award | A | Stock options | 30,000 | 2.54 | 76.2K | 30,000 | — | ↗ |
| 2012-05-21 | Waldman Lawrence | Director | A-Award | A | Stock options | 8,000 | 2.79 | 22.3K | 15,500 | — | ↗ |
| 2012-05-21 | Norman Michael G | Director | A-Award | A | Stock options | 6,000 | 2.79 | 16.7K | 111,000 | — | ↗ |
| 2012-05-21 | Lentricchia August | Director | A-Award | A | Stock options | 6,000 | 2.79 | 16.7K | 33,500 | — | ↗ |
| 2012-05-21 | Geraghty Michael | Director | A-Award | A | Stock options | 6,000 | 2.79 | 16.7K | 13,500 | — | ↗ |
| 2012-03-27 | MacLaren Steven | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-03-23 | Konesky Gregory Alan | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-03-18 | Waldman Lawrence | Director | — | D | Stock options | 7,500 | 2.81 | 21.1K | 0 | — | ↗ |
| 2012-03-18 | Geraghty Michael | Director | — | D | Stock options | 7,500 | 2.81 | 21.1K | 0 | — | ↗ |
| 2011-12-23 | Konesky Gregory Alan | Director | S-Sale | D | Common stock | 750 | 2.40 | 1.8K | 1,750 | — | ↗ |
| 2011-11-29 | CITRONOWICZ MOSHE | — | J-Other | D | Stock option | 25,000 | 3.25 | 81.3K | 50,000 | — | ↗ |
| 2011-08-25 | RENN Universal Growth Investment Trust | Director | P-Purchase | A | Common Stock | 7,100 | 2.70 | 19.2K | 1,247,800 | — | ↗ |
| 2011-08-24 | RENN Universal Growth Investment Trust | Director | P-Purchase | A | Common Stock | 14,100 | 2.66 | 37.5K | 1,240,770 | — | ↗ |
| 2011-08-23 | RENN Universal Growth Investment Trust | Director | P-Purchase | A | Common Stock | 11,600 | 2.55 | 29.6K | 1,226,600 | — | ↗ |
| 2011-08-09 | RENN Universal Growth Investment Trust | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 2.45 | 245.0K | 1,215,000 | — | ↗ |
| 2011-06-08 | KROMER GEORGE W | Director | S-Sale | D | Common stock | 5,000 | 2.87 | 14.4K | 261,508 | — | ↗ |
| 2011-05-20 | Konesky Gregory Alan | Director | S-Sale | D | Common stock | 800 | 2.99 | 2.4K | 2,500 | — | ↗ |
| 2011-03-15 | Pardoll Peter | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-03-07 | RENN Universal Growth Investment Trust | 10% Owner | P-Purchase | D | Common Stock | 150,000 | 2.57 | 385.5K | 1,100,000 | — | ↗ |
| 2011-03-02 | Keen Leonard | — | — | D | Stock options | 100,000 | 7.45 | 745.0K | 0 | — | ↗ |
| 2010-12-03 | Pardoll Peter | Director | S-Sale | D | Common stock | 6,078 | 3.08 | 18.7K | 60,651 | — | ↗ |
| 2010-12-02 | Pardoll Peter | Director | S-Sale | D | Common stock | 14,778 | 3.10 | 45.8K | 2,500 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-31.4K
Shares Outstanding
41.83M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Todd Hornsby Executive Vice President | 342.7K | — | — | 186.5K | — | 483.1K | 1.01M | 18.43% | ↗ |
| 2 | 2024 | Charles D. Goodwin CEO and Director | 501.8K | — | — | 453.3K | — | 20.9K | 976.0K | 46.44% | ↗ |
| 3 | 2024 | Mathew Hill CFO, Treasurer and Secretary | 425.0K | — | — | 279.8K | — | 75.4K | 780.2K | 35.86% | ↗ |
| 4 | 2024 | Moshe Citronowicz Senior Vice President | 324.0K | — | — | 134.3K | — | 25.2K | 483.5K | 27.78% | ↗ |
| 5 | 2024 | Shawn Roman Chief Operating Officer | 305.8K | — | — | 93.3K | — | 26.6K | 425.6K | 21.91% | ↗ |
| 6 | 2023 | Charles D. Goodwin CEO and Director | 482.5K | 306.4K | — | 448.3K | — | 24.3K | 1.26M | 35.54% | ↗ |
| 7 | 2023 | Tara Semb CFO, Treasurer and Secretary | 320.9K | 119.9K | — | 177.1K | — | 361.7K | 979.6K | 18.08% | ↗ |
| 8 | 2023 | Todd Hornsby Executive Vice President | 368.0K | 151.2K | — | 184.5K | — | 42.6K | 746.3K | 24.72% | ↗ |
| 9 | 2023 | Moshe Citronowicz Senior Vice President | 311.5K | 69.8K | — | 132.8K | — | 24.2K | 538.3K | 24.68% | ↗ |
| 10 | 2023 | Mathew Hill CFO, Treasurer and Secretary | 32.6K | 12.2K | — | — | — | — | 44.9K | 0.00% | ↗ |
| 11 | 2022 | Charles D. Goodwin CEO and Director | 482.5K | — | — | 1.66M | — | 22.9K | 2.17M | 76.71% | ↗ |
| 12 | 2022 | Todd Hornsby Executive Vice President | 368.0K | — | — | 685.1K | — | 26.8K | 1.08M | 63.44% | ↗ |
| 13 | 2022 | Tara Semb CFO, Treasurer and Secretary | 342.5K | — | — | 657.7K | — | 17.6K | 1.02M | 64.62% | ↗ |
| 14 | 2022 | Moshe Citronowicz Senior Vice President | 311.5K | — | — | 493.3K | — | 21.4K | 826.2K | 59.70% | ↗ |
| 15 | 2021 | Charles D. Goodwin CEO and Director | 450.0K | 421.9K | — | 701.4K | — | 21.1K | 1.59M | 43.99% | ↗ |
| 16 | 2021 | Todd Hornsby Executive Vice President | 347.0K | 216.9K | — | 288.7K | — | 26.8K | 879.3K | 32.83% | ↗ |
| 17 | 2021 | Tara Semb CFO, Treasurer and Secretary | 328.0K | 184.5K | — | 277.1K | — | 19.2K | 808.8K | 34.26% | ↗ |
| 18 | 2021 | Moshe Citronowicz Senior Vice President | 299.0K | 112.1K | — | 207.8K | — | 21.4K | 640.3K | 32.46% | ↗ |
| 19 | 2020 | Charles D. Goodwin CEO and Director | 450.0K | 168.8K | — | 1.20M | — | 19.1K | 1.83M | 65.20% | ↗ |
| 20 | 2020 | Todd Hornsby Executive Vice President | 347.0K | 86.8K | — | 491.8K | — | 28.7K | 954.3K | 51.54% | ↗ |
| 21 | 2020 | Tara Semb CFO, Treasurer and Secretary | 328.0K | 73.8K | — | 472.1K | — | 9.3K | 883.2K | 53.46% | ↗ |
| 22 | 2020 | Moshe Citronowicz Senior Vice President | 299.0K | 44.9K | — | 354.1K | — | 22.4K | 720.3K | 49.16% | ↗ |
| 23 | 2019 | Charles D. Goodwin CEO and Director | 450.0K | 344.3K | — | 1.14M | — | 15.8K | 1.95M | 58.36% | ↗ |
| 24 | 2019 | Todd Hornsby Executive Vice President | 330.0K | 168.3K | — | 365.6K | — | 28.4K | 892.3K | 40.97% | ↗ |
| 25 | 2019 | Moshe Citronowicz Senior Vice President | 270.0K | 82.6K | — | 346.3K | — | 22.4K | 721.4K | 48.01% | ↗ |
| 26 | 2019 | Tara Semb Chief Financial Officer, Treasurer and Secretary | 271.0K | 110.3K | — | 312.0K | — | 5.9K | 699.2K | 44.62% | ↗ |
| 27 | 2019 | Tara Semb CFO, Treasurer and Secretary | 271.0K | 110.3K | — | 312.0K | — | 5.9K | 699.2K | 44.62% | ↗ |
| 28 | 2018 | Charles D. Goodwin CEO and Director | 400.0K | 1.08M | — | — | — | 14.2K | 1.79M | 0.00% | ↗ |
| 29 | 2018 | J. Robert Saron President, Chief Sales & Marketing Officer & Director | 223.0K | 200.0K | — | — | — | 1.05M | 1.47M | 0.00% | ↗ |
| 30 | 2018 | Jay D. Ewers Former Chief Financial Officer, Treasurer and Secretary | 271.0K | 369.9K | — | 48.0K | — | 8.6K | 697.5K | 6.88% | ↗ |
| 31 | 2018 | Moshe Citronowicz Senior Vice President | 226.4K | 342.0K | — | — | — | 19.9K | 588.3K | 0.00% | ↗ |
| 32 | 2018 | Todd Hornsby Executive Vice President | 277.9K | 200.5K | — | — | — | 25.7K | 504.1K | 0.00% | ↗ |
| 33 | 2017 | Charles D. Goodwin CEO and Director | 15.4K | — | — | 1.77M | — | — | 1.79M | 99.14% | ↗ |
| 34 | 2017 | Robert L. Gershon CEO and Director | 436.0K | 122.1K | — | 196.2K | — | 29.4K | 783.6K | 25.04% | ↗ |
| 35 | 2017 | Todd Hornsby Executive Vice President | 504.2K | 300.00 | — | 206.4K | — | 25.1K | 736.0K | 28.05% | ↗ |
| 36 | 2017 | Jack McCarthy Chief Commercialization Officer | 287.4K | 59.2K | — | 137.3K | — | 27.2K | 511.1K | 26.87% | ↗ |
| 37 | 2017 | J. Robert Saron President, Chief Sales & Marketing Officer & Director | 334.5K | 300.00 | — | 137.3K | — | 19.8K | 491.9K | 27.92% | ↗ |
| 38 | 2017 | Jay D. Ewers Chief Financial Officer, Treasurer and Secretary | 271.0K | 300.00 | — | 137.3K | — | 8.5K | 417.1K | 32.92% | ↗ |
| 39 | 2017 | Jay D. Ewers Former Chief Financial Officer, Treasurer and Secretary | 271.0K | 300.00 | — | 137.3K | — | 8.5K | 417.1K | 32.93% | ↗ |
| 40 | 2017 | Moshe Citronowicz Senior Vice President | 226.4K | 300.00 | — | 137.3K | — | 19.0K | 383.0K | 35.86% | ↗ |
| 41 | 2016 | Robert L. Gershon CEO and Director | 365.8K | 293.7K | — | 65.6K | — | 30.2K | 755.3K | 8.69% | ↗ |
| 42 | 2016 | J. Robert Saron President, Chief Sales & Marketing Officer & Director | 318.9K | 149.0K | — | 32.4K | — | 24.4K | 524.6K | 6.17% | ↗ |
| 43 | 2016 | Jack McCarthy Chief Commercialization Officer | 287.4K | 134.3K | — | 32.4K | — | 29.9K | 483.9K | 6.69% | ↗ |
| 44 | 2016 | Moshe Citronowicz Senior Vice President | 214.0K | 100.1K | — | 32.4K | — | 22.1K | 368.5K | 8.78% | ↗ |
| 45 | 2016 | Jay D. Ewers Chief Financial Officer, Treasurer and Secretary | 235.0K | 109.9K | — | — | — | 10.6K | 355.5K | 0.00% | ↗ |
| 46 | 2016 | Jay D. Ewers Former Chief Financial Officer, Treasurer and Secretary | 235.0K | 109.9K | — | — | — | 10.6K | 355.5K | 0.00% | ↗ |
| 47 | 2016 | Todd Hornsby Executive Vice President | 321.0K | 500.00 | — | — | — | 17.2K | 338.6K | 0.00% | ↗ |
| 48 | 2016 | Andrew Makrides Executive Chairman of the Board | 215.5K | 100.3K | — | — | — | 18.6K | 334.5K | 0.00% | ↗ |
| 49 | 2015 | Robert L. Gershon CEO and Director | 350.0K | 180.0K | — | — | — | 30.2K | 560.2K | 0.00% | ↗ |
| 50 | 2015 | J. Robert Saron President, Chief Sales & Marketing Officer & Director | 305.2K | 79.5K | — | — | — | 24.4K | 409.1K | 0.00% | ↗ |
| 51 | 2015 | John J. McCarthy Chief Commercialization Officer | 275.0K | 74.5K | — | — | — | 29.9K | 379.4K | 0.00% | ↗ |
| 52 | 2015 | Jack McCarthy Chief Commercialization Officer | 275.0K | 74.5K | — | — | — | 29.9K | 379.4K | 0.00% | ↗ |
| 53 | 2015 | Jay D. Ewers Chief Financial Officer, Treasurer and Secretary | 171.5K | 65.3K | — | 70.7K | — | 32.2K | 339.6K | 20.81% | ↗ |
| 54 | 2015 | Andrew Makrides Executive Chairman of the Board | 238.6K | 56.3K | — | — | — | 18.6K | 313.6K | 0.00% | ↗ |
| 55 | 2015 | Moshe Citronowicz Senior Vice President | 204.8K | 53.5K | — | — | — | 22.1K | 280.4K | 0.00% | ↗ |
| 56 | 2014 | John J. McCarthy Chief Commercialization Officer | 201.5K | 100.5K | — | 336.5K | — | 12.4K | 650.9K | 51.70% | ↗ |
| 57 | 2014 | Jack McCarthy Chief Commercialization Officer | 201.5K | 100.5K | — | 336.5K | — | 12.4K | 650.9K | 51.70% | ↗ |
| 58 | 2014 | John J. McCarthy Chief Commercialization Officer | 201.5K | 100.5K | — | 336.5K | — | 12.4K | 650.9K | 51.70% | ↗ |
| 59 | 2014 | Robert L. Gershon CEO and Director | 350.0K | 175.5K | — | — | — | 19.7K | 545.2K | 0.00% | ↗ |
| 60 | 2014 | Robert L. Gershon CEO and Director | 350.0K | 175.5K | — | — | — | 19.7K | 545.2K | 0.00% | ↗ |
| 61 | 2014 | Peter L. Donato Chief Financial Officer, Treasurer and Secretary | 158.4K | 75.5K | — | 214.3K | — | 7.1K | 455.2K | 47.06% | ↗ |
| 62 | 2014 | J. Robert Saron President, Chief Sales Marketing Officer Director | 317.9K | 79.9K | — | — | — | 16.3K | 414.2K | 0.00% | ↗ |
| 63 | 2014 | J. Robert Saron President, Chief Sales & Marketing Officer & Director | 317.9K | 79.9K | — | — | — | 16.3K | 414.2K | 0.00% | ↗ |
| 64 | 2014 | Andrew Makrides Executive Chairman of the Board | 238.6K | 56.6K | — | — | — | 18.6K | 313.8K | 0.00% | ↗ |
| 65 | 2014 | Andrew Makrides Executive Chairman of the Board | 238.6K | 56.6K | — | — | — | 18.6K | 313.8K | 0.00% | ↗ |
| 66 | 2014 | Moshe Citronowicz Senior Vice President | 230.0K | 53.8K | — | — | — | 16.4K | 300.2K | 0.00% | ↗ |
| 67 | 2014 | Moshe Citronowicz Senior Vice President | 230.0K | 53.8K | — | — | — | 16.4K | 300.2K | 0.00% | ↗ |
| 68 | 2013 | Robert L. Gershon CEO and Director | 6.7K | 50.0K | — | 572.3K | — | 121.00 | 629.1K | 90.96% | ↗ |
| 69 | 2013 | Robert L. Gershon CEO and Director | 6.7K | 50.0K | — | 572.3K | — | 121.00 | 629.1K | 90.96% | ↗ |
| 70 | 2013 | Robert L. Gershon* CEO and Director | 6.7K | 50.0K | — | 572.3K | — | 629.1K | 629.1K | 90.96% | ↗ |
| 71 | 2013 | J. Robert Saron President, Chief Sales Marketing Officer Director | 305.2K | — | — | — | — | 20.6K | 325.7K | 0.00% | ↗ |
| 72 | 2013 | J. Robert Saron President, Chief Sales & Marketing Officer & Director | 305.2K | — | — | — | — | 20.6K | 325.7K | 0.00% | ↗ |
| 73 | 2013 | Andrew Makrides Executive Chairman of the Board | 215.5K | — | — | — | — | 15.8K | 231.3K | 0.00% | ↗ |
| 74 | 2013 | Andrew Makrides Executive Chairman of the Board | 215.5K | — | — | — | — | 15.8K | 231.3K | 0.00% | ↗ |
| 75 | 2013 | Moshe Citronowicz Senior Vice President | 204.8K | — | — | — | — | 14.8K | 219.6K | 0.00% | ↗ |
| 76 | 2013 | Moshe Citronowicz Senior Vice President | 204.8K | — | — | — | — | 14.8K | 219.6K | 0.00% | ↗ |
| 77 | 2013 | Peter L. Donato Chief Financial Officer, Treasurer and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 78 | 2013 | John J. McCarthy Chief Commercialization Officer | — | — | — | — | — | — | — | — | ↗ |
| 79 | 2012 | J. Robert Saron President, Chief Sales Marketing Officer Director | 297.1K | — | — | 28.5K | — | 22.0K | 347.7K | 8.20% | ↗ |
| 80 | 2012 | J. Robert Saron President, Chief Sales and Marketing Officer and Director | 297.1K | — | — | 28.5K | — | 22.0K | 347.7K | 8.20% | ↗ |
| 81 | 2012 | Jeff Rencher V.P. Sales Marketing | 160.1K | — | — | 164.5K | — | 15.7K | 340.3K | 48.35% | ↗ |
| 82 | 2012 | Andrew Makrides Chairman of the Board and CEO | 209.8K | — | — | 28.5K | — | 18.9K | 257.2K | 11.08% | ↗ |
| 83 | 2012 | Andrew Makrides Executive Chairman of the Board | 209.8K | — | — | — | — | 18.9K | 257.2K | 0.00% | ↗ |
| 84 | 2012 | Moshe Citronowicz Senior Vice President | 199.9K | — | — | 28.5K | — | 14.2K | 242.6K | 11.75% | ↗ |
| 85 | 2012 | Moshe Citronowicz Senior Vice President | 199.9K | — | — | — | — | 14.2K | 242.6K | 0.00% | ↗ |
| 86 | 2012 | Gary D. Pickett CFO, Treasurer, Secretary | 118.4K | — | — | 9.5K | — | 397.00 | 128.3K | 7.41% | ↗ |
| 87 | 2012 | Peter L. Donato Chief Financial Officer, Treasurer and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 88 | 2012 | Robert L. Gershon CEO and Director | — | — | — | — | — | — | — | — | ↗ |
| 89 | 2012 | John J. McCarthy Chief Commercialization Officer | — | — | — | — | — | — | — | — | ↗ |
| 90 | 2012 | Robert L. Gershon* CEO and Director | — | — | — | — | — | — | — | — | ↗ |
| 91 | 2011 | J. Robert Saron President, Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 19.3K | 310.0K | 0.00% | ↗ |
| 92 | 2011 | J. Robert Saron President, Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 19.3K | 310.0K | 0.00% | ↗ |
| 93 | 2011 | Moshe Citronowicz Senior Vice President | 212.2K | — | — | — | — | 16.5K | 228.7K | 0.00% | ↗ |
| 94 | 2011 | Moshe Citronowicz Senior Vice President | 212.2K | — | — | — | — | 16.5K | 228.7K | 0.00% | ↗ |
| 95 | 2011 | Andrew Makrides Chairman of the Board and CEO | 205.3K | — | — | — | — | 18.8K | 224.1K | 0.00% | ↗ |
| 96 | 2011 | Andrew Makrides CEO, Chairman of the Board | 205.3K | — | — | — | — | 18.8K | 224.1K | 0.00% | ↗ |
| 97 | 2011 | Leonard Keen Vice President and General Counsel (**) | 188.3K | — | — | — | — | 479.00 | 188.8K | 0.00% | ↗ |
| 98 | 2011 | Jeff Rencher V.P. Sales Marketing | 150.0K | — | — | — | — | 13.0K | 163.0K | 0.00% | ↗ |
| 99 | 2011 | Gary D. Pickett CFO, Treasurer, Secretary | 109.3K | — | — | — | — | 374.00 | 109.7K | 0.00% | ↗ |
| 100 | 2011 | Gary D. Pickett CFO, Treasurer, Secretary | 109.3K | — | — | — | — | 374.00 | 109.7K | 0.00% | ↗ |
| 101 | 2011 | Robert L. Gershon* CEO and Director | — | — | — | — | — | — | — | — | ↗ |
| 102 | 2010 | J. Robert Saron President, Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 9.2K | 299.8K | 0.00% | ↗ |
| 103 | 2010 | J. Robert Saron Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 9.2K | 299.8K | 0.00% | ↗ |
| 104 | 2010 | J. Robert Saron President, Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 9.2K | 299.8K | 0.00% | ↗ |
| 105 | 2010 | Leonard Keen Vice President and General Counsel (**) | 151.4K | — | — | — | — | 82.6K | 234.0K | 0.00% | ↗ |
| 106 | 2010 | Leonard Keen Vice President and General Counsel | 151.4K | — | — | — | — | 82.6K | 234.0K | 0.00% | ↗ |
| 107 | 2010 | Moshe Citronowicz Senior Vice President | 213.5K | — | — | — | — | 15.3K | 228.9K | 0.00% | ↗ |
| 108 | 2010 | Moshe Citronowicz Senior Vice President | 213.5K | — | — | — | — | 15.3K | 228.9K | 0.00% | ↗ |
| 109 | 2010 | Moshe Citronowicz Vice President Chief Operating Officer | 213.5K | — | — | — | — | 15.3K | 228.9K | 0.00% | ↗ |
| 110 | 2010 | Andrew Makrides President, CEO, Chairman of the Board | 205.3K | — | — | — | — | 19.5K | 224.8K | 0.00% | ↗ |
| 111 | 2010 | Andrew Makrides Chairman of the Board and CEO | 205.3K | — | — | — | — | 19.5K | 224.8K | 0.00% | ↗ |
| 112 | 2010 | Andrew Makrides CEO, Chairman of the Board | 205.3K | — | — | — | — | 19.5K | 224.8K | 0.00% | ↗ |
| 113 | 2010 | Gary D. Pickett CFO, Treasurer, Secretary | 102.0K | — | — | 9.8K | — | 374.00 | 112.1K | 8.74% | ↗ |
| 114 | 2010 | Gary D. Pickett CFO, Treasurer, Secretary | 102.0K | — | — | 9.8K | — | 374.00 | 112.1K | 8.74% | ↗ |
| 115 | 2010 | Jeff Rencher V.P. Sales Marketing | 70.0K | — | — | 19.5K | — | 538.00 | 90.0K | 21.66% | ↗ |
| 116 | 2009 | J. Robert Saron President, Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 11.0K | 301.6K | 0.00% | ↗ |
| 117 | 2009 | J. Robert Saron Chief Sales and Marketing Officer and Director | 290.7K | — | — | — | — | 11.0K | 301.6K | 0.00% | ↗ |
| 118 | 2009 | Moshe Citronowicz Vice President Chief Operating Officer | 213.5K | — | — | — | — | 14.1K | 227.6K | 0.00% | ↗ |
| 119 | 2009 | Moshe Citronowicz Senior Vice President | 213.5K | — | — | — | — | 14.1K | 227.6K | 0.00% | ↗ |
| 120 | 2009 | Andrew Makrides President, CEO, Chairman of the Board | 205.3K | — | — | — | — | 18.5K | 223.7K | 0.00% | ↗ |
| 121 | 2009 | Andrew Makrides CEO, Chairman of the Board | 205.3K | — | — | — | — | 18.5K | 223.7K | 0.00% | ↗ |
| 122 | 2009 | Steve Livneh President Bovie Canada*** | 190.2K | — | — | — | — | 1.8K | 192.1K | 0.00% | ↗ |
| 123 | 2009 | Gary D. Pickett CFO, Treasurer, Secretary | 101.2K | — | — | 43.8K | — | 483.00 | 145.4K | 30.09% | ↗ |
| 124 | 2009 | Leonard Keen Vice President and General Counsel (**) | — | — | — | — | — | — | — | — | ↗ |
| 125 | 2009 | Leonard Keen Vice President and General Counsel | — | — | — | — | — | — | — | — | ↗ |
| 126 | 2008 | J. Robert Saron Chief Sales and Marketing Officer and Director | 295.7K | 5.5K | — | — | — | 21.3K | 322.4K | 0.00% | ↗ |
| 127 | 2008 | Moshe Citronowicz Vice President Chief Operating Officer | 213.2K | 3.8K | — | — | — | 21.1K | 238.1K | 0.00% | ↗ |
| 128 | 2008 | Andrew Makrides President, CEO, Chairman of the Board | 208.6K | 3.9K | — | — | — | 20.6K | 233.0K | 0.00% | ↗ |
| 129 | 2008 | Steve Livneh President Bovie Canada*** | 165.0K | 2.7K | — | — | — | 6.6K | 174.3K | 0.00% | ↗ |
| 130 | 2008 | Gary D. Pickett CFO, Treasurer, Secretary | 104.1K | 2.0K | — | — | — | 3.3K | 109.4K | 0.00% | ↗ |
| 131 | 2008 | Leonard Keen Vice President and General Counsel | — | — | — | — | — | — | — | — | ↗ |
| 132 | 2007 | J. Robert Saron Chief Sales and Marketing Officer and Director | 276.7K | 5.2K | — | — | — | 20.4K | 302.3K | 0.00% | ↗ |
| 133 | 2007 | Steve Livneh President Bovie Canada | 203.3K | 3.5K | — | — | — | 16.2K | 263.2K | 0.00% | ↗ |
| 134 | 2007 | Moshe Citronowicz Vice President Chief Operating Officer | 203.3K | 3.8K | — | — | — | 20.1K | 227.3K | 0.00% | ↗ |
| 135 | 2007 | Andrew Makrides President, CEO, Chairman of the Board | 195.5K | 3.7K | — | — | — | 21.8K | 220.9K | 0.00% | ↗ |
| 136 | 2007 | Steve Livneh President Bovie Canada*** | 174.2K | 3.5K | — | — | — | 12.7K | 190.3K | 0.00% | ↗ |
| 137 | 2007 | Gary D. Pickett CFO, Treasurer, Secretary | 94.5K | 1.9K | — | 88.2K | — | 3.1K | 187.7K | 47.00% | ↗ |
| 138 | 2007 | Gary D. Pickett Chief Financial Officer and Secretary | 180.1K | 1.9K | — | 88.2K | — | — | 187.7K | 47.00% | ↗ |
| 139 | 2007 | J. Robert Saron President Aaron Medical and Director | — | 5.2K | — | — | — | 3.1K | 8.3K | 0.00% | ↗ |
| 140 | 2006 | J. Robert Saron President Aaron Medical and Director | — | 5.2K | — | — | — | — | 302.3K | 0.00% | ↗ |
| 141 | 2006 | Andrew Makrides President, CEO, Chairman of the Board | 217.4K | 3.7K | — | — | — | — | 240.7K | 0.00% | ↗ |
| 142 | 2006 | Moshe Citronowicz Vice President Chief Operating Officer | — | 3.8K | — | — | — | — | 227.3K | 0.00% | ↗ |
| 143 | 2006 | Steve Livneh President Bovie Canada | 242.9K | 2.9K | — | — | — | 16.5K | 190.3K | 0.00% | ↗ |
| 144 | 2006 | Gary D. Pickett Chief Financial Officer and Secretary | 94.5K | 1.7K | — | — | — | 13.4K | 109.6K | 0.00% | ↗ |
| 145 | 2006 | Vera MacElroy Secretary Director of Human Resources | 68.4K | 1.4K | — | — | — | — | 69.7K | 0.00% | ↗ |
| 146 | 2006 | Gary D. Pickett Chief Financial Officer | 66.4K | 1.7K | — | — | — | — | 68.2K | 0.00% | ↗ |
| 147 | 2005 | J. Robert Saron President Aaron Medical and Director | 276.7K | 4.9K | — | 56.3K | — | 1.5K | 302.5K | 18.59% | ↗ |
| 148 | 2005 | Moshe Citronowicz Vice President Chief Operating Officer | 249.9K | 3.6K | — | 56.3K | — | 20.4K | 265.3K | 21.20% | ↗ |
| 149 | 2005 | J. Robert Saron President of Aaron Medical and Director | 256.2K | 4.9K | — | 25.0K | — | — | 261.0K | 9.58% | ↗ |
| 150 | 2005 | Andrew Makrides President, CEO, Chairman of the Board | — | 3.4K | — | 56.3K | — | 19.6K | 253.2K | 22.22% | ↗ |
| 151 | 2005 | Moshe Citronowicz Executive Vice President- Chief Operating Officer | 193.5K | 3.6K | — | 25.0K | — | — | 197.0K | 12.69% | ↗ |
| 152 | 2005 | Gary D. Pickett Chief Financial Officer and Secretary | 66.4K | — | — | — | — | — | 69.7K | 0.00% | ↗ |
| 153 | 2005 | Vera MacElroy Secretary Director of Human Resources | 62.6K | 1.3K | — | — | — | — | 63.9K | 0.00% | ↗ |
| 154 | 2005 | Charles Peabody Chief | 50.5K | — | — | 25.0K | — | — | 50.5K | 49.49% | ↗ |
| 155 | 2005 | Steve Livneh President Bovie Canada | — | — | — | — | — | 20.1K | 40.7K | 0.00% | ↗ |
| 156 | 2005 | Gary D. Pickett Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 157 | 2004 | J. Robert Saron President Aaron Medical and Director | 233.0K | 4.5K | — | 53.3K | — | — | 290.8K | 18.31% | ↗ |
| 158 | 2004 | J. Robert Saron President of Aaron Medical and Director | 233.0K | 4.5K | — | 25.0K | — | 16.5K | 254.1K | 9.84% | ↗ |
| 159 | 2004 | J. Robert Saron President of Aaron Medical and Director | 233.0K | 4.5K | — | 25.0K | — | 16.5K | 254.1K | 9.84% | ↗ |
| 160 | 2004 | Moshe Citronowicz Vice President Chief Operating Officer | 170.8K | 3.3K | — | 53.3K | — | — | 227.3K | 23.42% | ↗ |
| 161 | 2004 | Andrew Makrides President, CEO, Chairman of the Board | 167.3K | 3.2K | — | 53.3K | — | — | 223.8K | 23.80% | ↗ |
| 162 | 2004 | Moshe Citronowicz Executive Vice President- Chief Operating Officer | 170.8K | 3.3K | — | 25.0K | — | 15.8K | 189.9K | 13.16% | ↗ |
| 163 | 2004 | Moshe Citronowicz Executive Vice President- Chief Operating Officer | 170.8K | 3.3K | — | 25.0K | — | 15.8K | 189.9K | 13.16% | ↗ |
| 164 | 2004 | Charles Peabody Chief | 81.8K | 1.6K | — | 25.0K | — | 7.9K | 91.3K | 27.38% | ↗ |
| 165 | 2004 | Vera MacElroy Secretary Director of Human Resources | 59.8K | 1.1K | — | — | — | — | 61.0K | 0.00% | ↗ |
| 166 | 2004 | Gary D. Pickett Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 167 | 2003 | J. Robert Saron President of Aaron Medical and Director | 219.8K | 4.2K | — | 110.0K | — | 15.6K | 239.6K | 45.92% | ↗ |
| 168 | 2003 | J. Robert Saron President of Aaron Medical and Director | 219.8K | 4.2K | — | 110.0K | — | 15.6K | 239.6K | 45.92% | ↗ |
| 169 | 2003 | Moshe Citronowicz Executive Vice President- Chief Operating Officer | 158.6K | 3.1K | — | 110.0K | — | 14.3K | 176.1K | 62.48% | ↗ |
| 170 | 2003 | Moshe Citronowicz Executive Vice President- Chief Operating Officer | 158.6K | 3.1K | — | 110.0K | — | 14.3K | 176.1K | 62.48% | ↗ |
| 171 | 2003 | Andrew Makrides President, CEO, Chairman of the Board | 158.4K | 3.0K | — | 110.0K | — | 9.9K | 171.3K | 64.21% | ↗ |
| 172 | 2003 | Charles Peabody Chief | 77.2K | 1.5K | — | 60.0K | — | 6.2K | 85.0K | 70.61% | ↗ |
| 173 | 2002 | J. Robert Saron President of Aaron Medical and Director | 200.5K | 3.9K | — | — | — | 15.5K | 220.0K | 0.00% | ↗ |
| 174 | 2002 | Moshe Citronowicz Executive Vice President- Chief Operating Officer | 147.4K | 2.9K | — | — | — | 15.7K | 165.9K | 0.00% | ↗ |
| 175 | 2002 | Andrew Makrides President, CEO, Chairman of the Board | 141.8K | 2.8K | — | — | — | 9.6K | 154.2K | 0.00% | ↗ |
| 176 | 2002 | Charles Peabody Chief | 76.2K | 1.5K | — | — | — | 6.1K | 83.8K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Charles D. Goodwin | President, Chief Executive Officer & Director | 951.9K | male |
| Matthew C. Hill | Chief Financial Officer, Treasurer & Secretary | 678.6K | male |
| Moshe Citronowicz | Senior Vice President | 451.7K | male |
| Shawn D. Roman | Chief Operating Officer | 426.1K | male |
| Stavros George Vizirgianakis | Executive Chairman | 27.1K | male |
| Dolores Catania | Chief of Confidence | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for APYX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
